Back to Search
GODOFREDO MATEO, MD
MD
General Practice Physician
NPI: 1912059122Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
MD00012743(WA)
Research & Publications (20)
Agonists and partial antagonists acting on the leptin--leptin receptor interface.
PMID 19400282·Adv Exp Med Biol·2009
8-other
Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease.
PMID 19003959·Int J Cancer·2009
8-other
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.
PMID 18669875·Blood·2008
3-trial
Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
PMID 18667930·J Acquir Immune Defic Syndr·2008
4-observational
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
PMID 18443352·J Clin Oncol·2008
3-trial
Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo.
PMID 18413862·Protein Sci·2008
7-preclinical
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
PMID 18322252·Haematologica·2008
3-trial
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.
PMID 18268286·Haematologica·2008
6-review
Strategies in the treatment of HIV-1-associated adipose redistribution syndromes.
PMID 17696790·Expert Opin Pharmacother·2007
6-review
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.
PMID 17576818·Blood·2007
8-other
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study.
PMID 16772605·Blood·2006
3-trial
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.
PMID 16740717·Cancer Res·2006
8-other
Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
PMID 16475149·Cancer·2006
4-observational
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.
PMID 16219573·Haematologica·2005
4-observational
Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
PMID 15897562·Clin Cancer Res·2005
8-other
Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
PMID 15794856·Clin Lymphoma·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7226 INTERLAAKEN DR SW
LAKEWOOD, WA 98499 - Phone
- (253) 588-4866
Quick Facts
- NPI
- 1912059122
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile